BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 17587825)

  • 1. Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo.
    Kokkinos MI; Wafai R; Wong MK; Newgreen DF; Thompson EW; Waltham M
    Cells Tissues Organs; 2007; 185(1-3):191-203. PubMed ID: 17587825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
    Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
    Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of epithelial-mesenchymal transition in breast cancer.
    Fuchs IB; Lichtenegger W; Buehler H; Henrich W; Stein H; Kleine-Tebbe A; Schaller G
    Anticancer Res; 2002; 22(6A):3415-9. PubMed ID: 12530097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
    Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
    Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
    Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive expression of RbAp46 induces epithelial-mesenchymal transition in mammary epithelial cells.
    Li GC; Wang ZY
    Anticancer Res; 2006; 26(5A):3555-60. PubMed ID: 17094482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis.
    Lou Y; Preobrazhenska O; auf dem Keller U; Sutcliffe M; Barclay L; McDonald PC; Roskelley C; Overall CM; Dedhar S
    Dev Dyn; 2008 Oct; 237(10):2755-68. PubMed ID: 18773493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
    Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
    Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
    Soltermann A; Tischler V; Arbogast S; Braun J; Probst-Hensch N; Weder W; Moch H; Kristiansen G
    Clin Cancer Res; 2008 Nov; 14(22):7430-7. PubMed ID: 19010860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition.
    Park MY; Kim KR; Park HS; Park BH; Choi HN; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
    Int J Oncol; 2007 Dec; 31(6):1309-15. PubMed ID: 17982656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
    Ghoul A; Serova M; Astorgues-Xerri L; Bieche I; Bousquet G; Varna M; Vidaud M; Phillips E; Weill S; Benhadji KA; Lokiec F; Cvitkovic E; Faivre S; Raymond E
    Cancer Res; 2009 May; 69(10):4260-9. PubMed ID: 19417139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in composition of keratin intermediate filaments in a model of breast cancer progression and the potential to reverse hallmarks of metastasis.
    Mackinder MA; Evans CA; Chowdry J; Staton CA; Corfe BM
    Cancer Biomark; 2012; 12(2):49-64. PubMed ID: 23396250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis.
    Vincan E; Brabletz T; Faux MC; Ramsay RG
    Cells Tissues Organs; 2007; 185(1-3):20-8. PubMed ID: 17587804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line.
    Hamada S; Satoh K; Hirota M; Kimura K; Kanno A; Masamune A; Shimosegawa T
    J Cell Physiol; 2007 Dec; 213(3):768-74. PubMed ID: 17516553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer.
    Javle MM; Gibbs JF; Iwata KK; Pak Y; Rutledge P; Yu J; Black JD; Tan D; Khoury T
    Ann Surg Oncol; 2007 Dec; 14(12):3527-33. PubMed ID: 17879119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappaB and epithelial to mesenchymal transition of cancer.
    Min C; Eddy SF; Sherr DH; Sonenshein GE
    J Cell Biochem; 2008 Jun; 104(3):733-44. PubMed ID: 18253935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen.
    Li Q; Chen C; Kapadia A; Zhou Q; Harper MK; Schaack J; LaBarbera DV
    J Biomol Screen; 2011 Feb; 16(2):141-54. PubMed ID: 21297102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
    Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
    J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal transition and colorectal cancer: gaining insights into tumor progression using LIM 1863 cells.
    Bates RC; Pursell BM; Mercurio AM
    Cells Tissues Organs; 2007; 185(1-3):29-39. PubMed ID: 17587805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction pathways involved in epithelial-mesenchymal transition in oral cancer compared with other cancers.
    Chang JY; Wright JM; Svoboda KK
    Cells Tissues Organs; 2007; 185(1-3):40-7. PubMed ID: 17587806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.